Please use this identifier to cite or link to this item:
https://swslhd.intersearch.com.au/swslhdjspui/handle/1/13060
Title: | Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study |
Author: | Yeung, D. T. Shanmuganathan, N. Reynolds, J. Branford, S. Walia, M. Yong, A. S. M. Shortt, J. Chee, L. Viiala, N. Cunningham, I. Ross, D. M. D'Souza, A. Wright, M. Harrup, R. Forsyth, C. Filshie, R. Lane, S. Browett, P. Grove, C. Grigg, A. P. Hughes, T. P. Viiala, N. |
Issue Date: | 2024 |
Journal: | Blood |
Abstract: | Asciminib is a myristoyl site BCR |
ISSN: | 00064971 (ISSN) |
Digital object identifier: | 10.1182/blood.2024024657 |
URI: | https://swslhd.intersearch.com.au/swslhdjspui/handle/1/13060 |
Appears in Collections: | Liverpool Hospital |
Files in This Item:
There are no files associated with this item.
Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.